Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00119210Phase 4Terminated
Phase 4, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Bupropion SR with Placebo (2 arms). Primary endpoints: Proportion of women who are eligible for the study, Proportion of eligible women who enroll in the study and 1 more. Started Mar 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00119210.